SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Izzy who wrote (3578)1/10/1998 7:09:00 PM
From: JOHN W.   of 6136
 
Actually, MS has a 53 twelve month tgt. But also note PW still has a 65-70, and RS&C still higher. And as margie has noted estimates continue to rise. Yes the Roche announcement was a surprise, but I agree with L. Moss in that if you believe in the potential of AG3340 or 2034, the deal leads to more long term valuation and increases the intrinsic value of the company. This years price will generally track Viracept sales and the overall mkt, which in itself could easily generate the PW tgt
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News